> Subject: Re: I'm back > From: dpatel <[log in to unmask]> > Date: Thu, 12 Jul 2001 12:32:04 -0400 Dear Jacob, Sorry that you did not receive a response. Amgen is something that I am keeping an eye on myself. Most of the info I have found is from another board. I am posting a link below to help you. The board is MGH- Neurology forum. http://neuro-mancer.mgh.harvard.edu/ubb/Forum71/HTML/004848.html. If you do a search using the term 'Amgen' pn this board you will find many other related topics. If I can assist further, do please write back. I hope this helps you in some way. Dabu ----- Original Message ----- From: "Jacob M. Drollinger" <[log in to unmask]> To: <[log in to unmask]> Sent: Monday, July 09, 2001 3:58 PM Subject: I'm back > Dear friends, > > For some of you who were around two+ years ago, I will re-introduce myself. > For others who are relatively new to the list, mine is a new name. > About 12 1/2 years ago, I attemped suicide by CO poisoning. I ended up with > bi-lateral lesions to both internal and external GP. The resulting disability > was similar to P.D. in that I exhibited some of the classic symptoms: > rigidity, bradykinesia, dystonia, balance problems, and speech impairments. > However, the one thing I lack is tremor. > I came back to the list to discuss recent developments in treating > neurological disorders in general, and Parkinson's to be more specific. I am > especially interested in the clinical trials being done on P.D. patients with > the neuroimmunophilin ligands compound manufactured by Amgen. > Is anyone on the list taking part in the trials, and if so, what, if any, > positive results have you seen so far? Has anyone heard anything on phase II? > > Jacob M. Drollinger Jr. 30 years old/diagnosed 12 years ago. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn